These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 127774)

  • 1. Comparison of cervical Pap smears with subsequent diagnosis of cervical carcinoma an analysis of Arkansas health department Pap smears for 1970 and 1971.
    Steinkamp RC; Harden VA; Deneke JS; Uyeda CK
    J Ark Med Soc; 1975 Sep; 72(4):168-71. PubMed ID: 127774
    [No Abstract]   [Full Text] [Related]  

  • 2. [Computer-assisted screening for cervical carcinoma--the results for a 10-year period].
    Neumann HG; Seidenschnur G
    Arch Geschwulstforsch; 1987; 57(2):129-39. PubMed ID: 3296989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of physical findings in diagnosis of cervical carcinoma.
    Moller KA; Fogh H; Moller PE; Strandbygard K
    Dan Med Bull; 1972 Jun; 19(4):122-7. PubMed ID: 5041568
    [No Abstract]   [Full Text] [Related]  

  • 4. Profile of Pap smear cytology in the Western region of Saudi Arabia.
    Jamal A; Al-Maghrabi JA
    Saudi Med J; 2003 Nov; 24(11):1225-9. PubMed ID: 14647558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan.
    Sung HY; Kearney KA; Miller M; Kinney W; Sawaya GF; Hiatt RA
    Cancer; 2000 May; 88(10):2283-9. PubMed ID: 10820350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Carcinoma in situ of the cervix uteri, its detection and treatment].
    Klein R; Kremer H; Narik G
    Osterr Z Erforsch Bekampf Krebskr; 1970; 25(6):413-20. PubMed ID: 5537785
    [No Abstract]   [Full Text] [Related]  

  • 7. [1-year results in the detection of precanceroses and carcinoma of the uterine cervix in Baranja].
    Milojković M; Pajtler M; Makarović Z; Lederer B; Jarcov R
    Jugosl Ginekol Perinatol; 1986; 26(5-6):119-22. PubMed ID: 3657276
    [No Abstract]   [Full Text] [Related]  

  • 8. Frequency of cancer of the cervix in a West Virginia county.
    Eckert HL; Krall JM
    W V Med J; 1972 Jun; 68(6):158-60. PubMed ID: 4504383
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of the suspicious Pap smear.
    Scott WC
    Ariz Med; 1972 Aug; 29(8):639-41. PubMed ID: 4559071
    [No Abstract]   [Full Text] [Related]  

  • 11. Low Pap smear rates leave women at risk.
    Golden WE; Hickman N
    J Ark Med Soc; 2004 Jun; 100(12):426-7. PubMed ID: 15200282
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of visual inspection and Papanicolau (PAP) smears for cervical cancer screening in Honduras: should PAP smears be abandoned?
    Perkins RB; Langrish SM; Stern LJ; Figueroa J; Simon CJ
    Trop Med Int Health; 2007 Sep; 12(9):1018-25. PubMed ID: 17875013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Health examination in Malmöhus County for the diagnosis of pre-invasive cervical cancer].
    Ahlgren M; Lindberg LG; Nordqvist S; Stormby N
    Lakartidningen; 1971 Jun; 68(30):3389-97. PubMed ID: 5096169
    [No Abstract]   [Full Text] [Related]  

  • 14. Arkansas cervical cancer program.
    Steinkamp RC; Roman-Lopez J; Kenney JA; Hairston MG; Hylton S; Hammett WN; Marsh S; Becton P; Collier S
    J Ark Med Soc; 1980 Jan; 76(1):312-22. PubMed ID: 6444400
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytohistologic correlation rates between conventional Papanicolaou smears and ThinPrep cervical cytology: a comparison.
    Chacho MS; Mattie ME; Schwartz PE
    Cancer; 2003 Jun; 99(3):135-40. PubMed ID: 12811853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of the Pap-test in the cervical cytological screening].
    Giannone R; Piacezzi C; Poli M; Bernorio R
    Minerva Ginecol; 1992 Apr; 44(4):155-9. PubMed ID: 1584446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAP smear after radiation therapy for cervical carcinoma.
    Rintala MA; Rantanen VT; Salmi TA; Klemi PJ; Grénman SE
    Anticancer Res; 1997; 17(5B):3747-50. PubMed ID: 9427773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cervical cancer screening and associated treatment costs in France].
    Bergeron C; Breugelmans JG; Bouée S; Lorans C; Bénard S; Rémy V
    Gynecol Obstet Fertil; 2006 Nov; 34(11):1036-42. PubMed ID: 17070085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Policy following review of Pap class IIIA in mass screening for cervix carcinoma].
    Ned Tijdschr Geneeskd; 1987 Jan; 131(1):28-30. PubMed ID: 3821969
    [No Abstract]   [Full Text] [Related]  

  • 20. [Differential diagnosis of atypic cells in smears with suspected carcinoma].
    Wagner D; Hilgarth M; Isebarth H
    Med Lab (Stuttg); 1971 Mar; 24(3):65-70. PubMed ID: 5572478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.